APXH Fees and Costs — APEX Healthcare ETF

Data updated: 2022-12-28

The net expense ratio is 0.95% (5.85% before fee waivers). There are no sales loads or redemption fees. In fiscal 2022 the fund paid $6K in broker commissions, 0.1557% of average net assets, and portfolio turnover was 78%.

APXH Fees and Expenses

Annual operating expenses and sales charges of APXH. Prospectus, as of November 30, 2022.

Annual operating expenses
Management fee0.75%
12b-1 fee0.00%
Other expenses5.05%
Gross expense ratio5.85%
Fee waiver−4.90%
Net expense ratio0.95%
Sales charges
Max front load—
Max deferred load—
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

APXH Costs Over Time

On $10,000 invested in APXH, assuming 5% a year before costs, total costs come to $690 over 5 years, cutting the return by 1.16% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 0.95%)$100$311$539
Trading costs (broker commissions)$16$51$88
Lost growth on money paid in costs$0$18$63
Total costs$116$380$690
Value after costs$10,384$11,196$12,073
Impact on return, per year1.16%1.16%1.16%

APXH Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending July 31, 2022.

  • Explicit cost rate (commissions ÷ average net assets): 0.1557%
  • Total broker commissions: $6K
  • Bought from dealers (principal trades, not a cost): $6.8M
  • Portfolio turnover (prospectus): 78%
  • Securities lending: none during the year

APXH Agency Brokers

Commissions paid.

BrokerAmountShare
MISCHLER FINANCIAL GROUP$6K100.00%

APXH Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
Goldman Sachs$4.0M58.41%
VIRTU FINANCIAL CAPITAL MARKETS$2.2M32.21%
JANE STREET EXECUTION SERVICES, LLC$642K9.38%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.